Cheinquer, Hugo

Publishing since 2001 (Junior)

Has published 14 publications in 10 years

Number of publications published per year by Cheinquer, Hugo. (Source : PubMed)

Distribution of publications types for Cheinquer, Hugo. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Recent publications

•  Silva DR, Stifft J, Cheinquer H, Knorst MM. Prevalence of hepatitis C virus infection in patients with COPD.  Epidemiol. Infect.  2010;138;2  
•  Chang TT, Chao YC, Gorbakov VV, Han KH, Gish RG, de Man R, Cheinquer H, Bessone F, Brett-Smith H, Tamez R. Results of up to 2 years of entecavir vs lamivudine therapy in nucleoside-naïve HBeAg-positive patients with chronic hepatitis B.  J. Viral Hepat.  2009;16;11  
•  Nita ME, Gaburo N, Cheinquer H, L'Italien G, Affonso de Araujo ES, Mantilla P, Cure-Bolt N, Lotufo PA. Patterns of viral load in chronic hepatitis B patients in Brazil and their association with ALT levels and HBeAg status.  Ann Hepatol  2009;8;4  
•  Shouval D, Lai CL, Chang TT, Cheinquer H, Martin P, Carosi G, Han S, Kaymakoglu S, Tamez R, Yang J, Tenney D, Brett-Smith H. Relapse of hepatitis B in HBeAg-negative chronic hepatitis B patients who discontinued successful entecavir treatment: the case for continuous antiviral therapy.  J. Hepatol.  2009;50;2  
•  Daruich J, Gadano A, Fainboim H, Pessoa M, Cheinquer H. [Latin American guideline for the treatment of chronic hepatitis B]  Acta Gastroenterol. Latinoam.  2007;37;3  
•  Hernández N, Chirino R, Fassio E, Cheinquer H. [Hepatitis A and B vaccines]  Rev Gastroenterol Mex  2006;71 Suppl 2  
•  Galperim B, Cheinquer H, Stein A, Fonseca A, Lunge V, Ikuta N. Prevalence of hepatitis C virus in alcoholic patients: role of parenteral risk factors.  Arq Gastroenterol  2006;43;2  
•  Lai CL, Shouval D, Lok AS, Chang TT, Cheinquer H, Goodman Z, DeHertogh D, Wilber R, Zink RC, Cross A, Colonno R, Fernandes L. Entecavir versus lamivudine for patients with HBeAg-negative chronic hepatitis B.  N. Engl. J. Med.  2006;354;10  
•  Parise E, Cheinquer H, Crespo D, Meirelles A, Martinelli A, Sette H, Gallizi J, Silva R, Lacet C, Correa E, Cotrim H, Fonseca J, Paraná R, Spinelli V, Amorim W, Tatsch F, Pessoa M. Peginterferon alfa-2a (40KD) (PEGASYS) plus ribavirin (COPEGUS) in retreatment of chronic hepatitis C patients, nonresponders and relapsers to previous conventional interferon plus ribavirin therapy.  Braz J Infect Dis  2006;10;1  
•  Dittrich S, de Mattos AA, Cheinquer H, de Araújo FB. [Correlation between platelet blood levels and the hepatic venous pressure gradient among patients with cirrhosis]  Arq Gastroenterol  2005;42;1  

[ See timeline ] [ See all publications ]